ResMed (RMD:AX) launched its US Food and Drug Administration-cleared home sleep apnea test, NightOwl, across the US, according to a Friday statement by the company.

The fingertip sensor allows individuals to test for obstructive sleep apnea at home, the statement said.

Shares of the company fell nearly 3% in recent Friday trade.